Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study

被引:1
|
作者
Rosenkranz, Simone H. [1 ]
Wichmand, Charlotte H. [1 ]
Smedegaard, Laerke [1 ]
Moller, Sidsel [1 ,2 ]
Bjerre, Jenny [1 ]
Schou, Morten [1 ]
Torp-Pedersen, Christian [3 ,4 ]
Philbert, Berit T. [5 ]
Larroude, Charlotte [1 ]
Melchior, Thomas M. [6 ]
Nielsen, Jens C. [7 ,8 ]
Johansen, Jens B. [9 ]
Riahi, Sam [10 ,11 ]
Holmberg, Teresa [12 ]
Gislason, Gunnar [1 ,13 ,14 ]
Ruwald, Anne-Christine [5 ,6 ]
机构
[1] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Hellerup, Denmark
[2] Emergency Med Serv Copenhagen, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
[4] Nordsjaellands Hosp, Dept Cardiol, Hillerod, Denmark
[5] Copenhagen Univ Hosp, Rigshospitalet, Dept Cardiol, Copenhagen, Denmark
[6] Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark
[7] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[8] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[9] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[10] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[11] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
[12] Danish Canc Soc, Res Ctr, Copenhagen, Denmark
[13] Danish Heart Fdn, Copenhagen, Denmark
[14] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
关键词
Implantable Cardioverter Defibrillator; Workforce affiliation; Return-to-work; Employment maintenance; Epidemiology; Risk markers; HEART-FAILURE; SICK-LEAVE; FOLLOW-UP; ICD; HEALTH; DEPRESSION; IMPACT; RISK; UNEMPLOYMENT; EMPLOYMENT;
D O I
10.1093/ehjqcco/qcad054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim There are a paucity of studies investigating workforce affiliation in connection with first-time implantable cardioverter defibrillator (ICD)-implantation. This study explored workforce affiliation and risk markers associated with not returning to work in patients with ICDs.Methods Using the nationwide Danish registers, patients with a first-time ICD-implantation between 2007 and 2017 and of working age (30-65 years) were identified. Descriptive statistic and logistic regression models were used to describe workforce affiliation and to estimate risk markers associated with not returning to work, respectively. All analyses were stratified by indication for implantation (primary and secondary prevention).Results Of the 4659 ICD-patients of working age, 3300 patients (71%) were members of the workforce (employed, on sick leave or unemployed) (primary: 1428 (43%); secondary:1872 (57%)). At baseline, 842 primary and 1477 secondary prevention ICD-patients were employed. Of those employed at baseline, 81% primary and 75% secondary prevention ICD-patients returned to work within 1 year, whereof more than 80% remained employed the following year. Among patients receiving sick leave benefits at baseline, 25% were employed after 1 year. Risk markers of not returning to work were 'younger age' in primary prevention ICD-patients, while 'female sex', left ventricular ejection fraction 'LVEF & LE;40', 'lower income', and '& GE;3 comorbidities' were risk markers in secondary prevention ICD-patients. Lower educational level was a risk marker in both patient groups.Conclusion High return-to-work proportions following ICD-implantation, with a subsequent high level of employment maintenance were found. Several significant risk markers of not returning to work were identified including 'lower educational level' that posed a risk in both patient groups.Trial registration number Capital Region of Denmark, P-2019-051. Graphical Abstract Workforce affiliation in primary and secondary prevention ICD-patients.
引用
收藏
页码:314 / 325
页数:12
相关论文
共 50 条
  • [21] Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients
    van Welsenes, Guido H.
    van Rees, Johannes B.
    Borleffs, C. Jan Willem
    Cannegieter, Suzanne C.
    Bax, Jeroen J.
    van Erven, Lieselot
    Schalij, Martin J.
    EUROPACE, 2011, 13 (03): : 389 - 394
  • [22] Implantable cardioverter defibrillator - powerful weapon in primary and secondary prevention of sudden cardiac death
    Kostic, Tomislav
    Stanojevic, Dragana
    Gudelj, Ognjen
    Milic, Dragan
    Putnik, Svetozar
    Perisic, Zoran
    Djindjic, Boris
    Pavlovic, Milan
    Koracevic, Goran
    Golubovic, Mladjan
    Mitov, Vladimir
    Momcilovic, Stefan
    Bankovic, Sanja
    VOJNOSANITETSKI PREGLED, 2019, 76 (10) : 1007 - 1013
  • [23] Natural history of hemodialysis patients receiving an implantable cardioverter defibrillator for secondary prevention
    Dobesh, DP
    Stein, K
    Mittal, S
    Iwai, S
    Shah, B
    Cheung, J
    Tan, V
    Nemirovsky, D
    Dhruvakumar, S
    Lerman, B
    Markowitz, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 15A - 15A
  • [24] Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
    Sarrias, Axel
    Galve, Enrique
    Sabate, Xavier
    Moya, Angel
    Anguera, Ignacio
    Nunez, Elaine
    Villuendas, Roger
    Alcalde, Oscar
    Garcia-Dorado, David
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (06): : 492 - 496
  • [25] Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
    Rahmawati, Anita
    Chishaki, Akiko
    Ohkusa, Tomoko
    Sawatari, Hiroyuki
    Tsuchihashi-Makaya, Miyuki
    Ohtsuka, Yuko
    Nakai, Mori
    Miyazono, Mami
    Hashiguchi, Nobuko
    Sakurada, Harumizu
    Takemoto, Masao
    Mukai, Yasushi
    Inoue, Shujirou
    Sunagawa, Kenji
    Chishaki, Hiroaki
    JOURNAL OF ARRHYTHMIA, 2016, 32 (02) : 102 - 107
  • [26] Implantable Cardioverter Defibrillator Criteria for Primary and Secondary Prevention of Pediatric Sudden Cardiac Death
    Berul, Charles I.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 : S67 - S70
  • [27] Comment on: Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients
    Zakiev, Vadim
    Gvozdeva, Anna
    Skotnikov, Anton
    CLINICAL CARDIOLOGY, 2024, 47 (02)
  • [28] Incidence of adequate and inadequate therapies in patients with an implantable Cardioverter Defibrillator for primary prevention
    Kreuz, J.
    Balta, O.
    Liliegren, N.
    Ezmailzadeh, B.
    Schneider, C.
    Welz, A.
    Nickenig, G.
    Schwab, J. O.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2007, 21 (01): : 8 - 12
  • [29] Clinical Outcomes and Mortality in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention
    Baskurt, Ahmet Anil
    Guneri, Sema
    Yilancioglu, Resit Yigit
    Turan, Oguzhan Ekrem
    Ozcan, Emin Evren
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2025, 122 (02)
  • [30] Incidence of arrhythmic events in patients with implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death
    Capoferri, M
    Schwick, N
    Tanner, H
    Fuhrer, J
    Delacretaz, E
    SWISS MEDICAL WEEKLY, 2004, 134 (11-12) : 154 - 158